FBRX

Conviction 42HealthcareScan · Fri, Jun 26, 2026

FBRX$20.87+11.54%

ResistanceSupportVol 14

Vol MA14 311.29K

Mar 27Apr 15May 4May 20Jun 9Jun 26

Forte Biosciences, Inc.PHARMACEUTICAL PREPARATIONSwww.fortebiorx.com ↗

Price20.87

Change+11.54%

Gap-0.86%

Rel volume5.15×

Avg volume326.03K

Avg $ vol5.98M

SMA 2017.82

SMA 5022.70

SMA 20022.52

Price vs 50-8.05%

Price vs 200-7.34%

MA stackmixed

50/200 cross—

Supertrenddown · 21.54

RSI (14)57

MACD hist0.64

MACD crossbull · 9d

Stoch %K / %D89 / 85

ADX (14)24

+DI / −DI23 / 18

RSI divergence—

MACD divergence—

ATR %+7.85%

ADR %8.17%

52w high35.53

52w low9.45

From 52w high-41.26%

Above 52w low+120.85%

New 52w highNo

SqueezeOff

Bollinger width25.29%

%B1.18

Donchian pos89.04%

Donchian high21.53

Donchian low15.51

AVWAP (52w high)25.06

vs AVWAP high-16.71%

AVWAP (52w low)24.28

vs AVWAP low-14.05%

OBV trendFlat

Chaikin MF (20)-0.00

Today vs 20d5.15×

Avg vol (14d)311.29K

Avg vol (20d)326.03K

Avg $ vol (20d)5.98M

Market cap—

RS 3m (vs SPY)-40.87%

RS 6m (vs SPY)-43.43%

RS line new highNo

Trend template3/8

Technical rank32.6

1 week+16.92%

1 month-2.79%

3 months-22.73%

6 months-21.67%

1 year+97.07%

YTD-11.61%

P/E-3.75

P/B6.17

P/S—

P/FCF-5.10

EPS-4.71

Div yield—

ROE-164.79%

ROA-103.20%

Debt/Eq0.52

Current2.75

EV/EBITDA—

Gross margin—

Net margin—

Rev growth-99.80%

EPS growth-95.54%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value223.8M

Revenue9K

Net income-22.14M

Gross profit—

Free cash flow-51M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out20.48M

Employees22

ListedTue, Jun 16, 2020

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction42 / 100

Pattern quality—

Tech rank32.6 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance28.72

Support16.20

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in FBRX

All disclosures →

No recent disclosed trades by Congress in FBRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in FBRX · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Kornfeld Steven Director · Restricted Stock Units · 2026-05-29	Grant	18.35K	$0	2026-05-29	2026-06-02
Kapoor Shivpreet Singh Director · Restricted Stock Units · 2026-05-29	Grant	18.35K	$0	2026-05-29	2026-06-02
GRYSKA DAVID W Director · Restricted Stock Units · 2026-05-29	Grant	18.35K	$0	2026-05-29	2026-06-02
Doberstein Stephen K Director · Restricted Stock Units · 2026-05-29	Grant	18.35K	$0	2026-05-29	2026-06-02
Brun Scott C. Director · Restricted Stock Units · 2026-05-29	Grant	18.35K	$0	2026-05-29	2026-06-02
VINCENT RICHARD G Director · Restricted Stock Units · 2026-05-29	Grant	18.35K	$0	2026-05-29	2026-06-02

SEC filings

EDGAR filings in FBRX · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.